Breaking News Instant updates and real-time market news.

2020-08-10 09:17:06 VRNA Verona Pharma $7.78 / +0.81 (+11.62%) 09:17 08/10/20 08/10 09:17 08/10/20 09:17	Canaccord starts Verona Pharma with a Buy rating, $17 price target As previously reported, Canaccord analyst Edward Nash initiated coverage of Verona Pharma with a Buy rating and $17 price target. The company is developing Ensifentrine, a dual phosphodiesterase 3 and 4 inhibitor, for chronic obstructive pulmonary disease, or COPD. The company's ENHANCE program includes two studies, ENHANCE-1 and ENHANCE-2, to evaluate the safety and efficacy of nebulized ensifentrine BID as monotherapy and as an add-on to standard-of-care treatment with a single LAMA or LABA bronchodilator, Nash told investors. Verona completed an approximate $200M financing for the ENHANCE program in July.	11 Aug 14 Aug
VRNA Verona Pharma $7.78 / +0.81 (+11.62%) 08/10/20 Canaccord Verona Pharma initiated with a Buy at Canaccord 04/21/20 Wedbush Verona Pharma price target lowered to $50 from $60 at Wedbush 01/14/20 Truist Verona Pharma price target raised to $34 from $29 at SunTrust 01/13/20 Wedbush Verona Pharma price target raised to $60 after Phase 2b COPD study hits

2020-08-10 09:17:06

VRNA

Verona Pharma

$7.78 / +0.81 (+11.62%)

09:17

08/10/20

08/10

09:17

08/10/20

09:17

Canaccord starts Verona Pharma with a Buy rating, $17 price target

As previously reported, Canaccord analyst Edward Nash initiated coverage of Verona Pharma with a Buy rating and $17 price target. The company is developing Ensifentrine, a dual phosphodiesterase 3 and 4 inhibitor, for chronic obstructive pulmonary disease, or COPD. The company's ENHANCE program includes two studies, ENHANCE-1 and ENHANCE-2, to evaluate the safety and efficacy of nebulized ensifentrine BID as monotherapy and as an add-on to standard-of-care treatment with a single LAMA or LABA bronchodilator, Nash told investors. Verona completed an approximate $200M financing for the ENHANCE program in July.

11
Aug
14
Aug

VRNA Verona Pharma

$7.78 / +0.81 (+11.62%)

08/10/20 Canaccord: Verona Pharma initiated with a Buy at Canaccord

04/21/20 Wedbush: Verona Pharma price target lowered to $50 from $60 at Wedbush

01/14/20 Truist: Verona Pharma price target raised to $34 from $29 at SunTrust

01/13/20 Wedbush: Verona Pharma price target raised to $60 after Phase 2b COPD study hits

TODAY'S FREE FLY STORIES

Downgrade	Cadence Bancorp downgraded to Market Perform from Outperform at Raymond James » 07:44 04/13/21 04/13 07:44 04/13/21 07:44 CADE Cadence Bancorp $22.41 / +0.92 (+4.28%) , BXS BancorpSouth $30.45 / -1.79 (-5.55%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CADE BXS CADE Cadence Bancorp $22.41 / +0.92 (+4.28%) 04/12/21 Cadence Bancorp rises 7.1% 04/12/21 BancorpSouth, Cadence Bancorp announce all-stock merger agreement 01/25/21 Cadence Bancorp reports book value per share $15.83 as of December 31 01/25/21 Cadence Bancorp raises dividend to 15c BXS BancorpSouth $30.45 / -1.79 (-5.55%) 04/12/21 BancorpSouth, Cadence Bancorp announce all-stock merger agreement 04/07/21 BancorpSouth gets FDIC approval of mergers with National United, FNS Bancshares 01/13/21 BancorpSouth Bank to acquire FNS Bancshares for $90.04 per share 12/09/20 BancorpSouth announces new 6M share repurchase authorization CADE BXS CADE Cadence Bancorp $22.41 / +0.92 (+4.28%) 07:28 Today Truist Cadence Bancorp downgraded to Hold from Buy at Truist 06:37 Today Raymond James Cadence Bancorp downgraded to Market Perform from Outperform at Raymond James 06:10 Today RBC Capital Cadence Bancorp downgraded to Sector Perform from Outperform at RBC Capital 04/12/21 RBC Capital Cadence Bancorp downgraded to Sector Perform from Outperform at RBC Capital BXS BancorpSouth $30.45 / -1.79 (-5.55%) 07:28 Today Truist Cadence Bancorp downgraded to Hold from Buy at Truist 06:10 Today RBC Capital Cadence Bancorp downgraded to Sector Perform from Outperform at RBC Capital 12/03/20 Stephens National United deal shouldn't preclude more M&A at BancorpSouth, says Stephens 11/16/20 DA Davidson BancorpSouth downgraded to Neutral from Buy at DA Davidson CADE BXS CADE Cadence Bancorp $22.41 / +0.92 (+4.28%) 01/25/21 Cadence Bancorp reports Q4 adjusted EPS $1.57, consensus $1.48 10/21/20 Cadence Bancorp reports Q3 EPS 40c, consensus 19c BXS BancorpSouth $30.45 / -1.79 (-5.55%) 01/25/21 BancorpSouth reports Q4 operating EPS ex MSR 69c, consensus 62c 10/21/20 BancorpSouth reports Q3 EPS 69c, consensus 53c CADE CADE Cadence Bancorp $22.41 / +0.92 (+4.28%) 01/07/21 Fly Intel: After-Hours Movers 04/22/21 Cadence Bancorp - CADE 04/22/21 BancorpSouth - BXS 05/06/21 Cadence Bancorporation
Hot Stocks	American Airlines sees ending Q1 with $17.3B in total available liquidity » 07:43 04/13/21 04/13 07:43 04/13/21 07:43 AAL American Airlines $22.92 / -0.625 (-2.66%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options AAL American Airlines $22.92 / -0.625 (-2.66%) 04/05/21 CDC issues updated guidance on travel for fully vaccinated people 03/31/21 American Airlines repays $2.8B in revolving loans related to COVID 03/29/21 American Airlines now sees Q1 system capacity down 40%-45%, up from prior view 03/08/21 American Airlines announces proposed offering of senior secured notes AAL American Airlines $22.92 / -0.625 (-2.66%) 04/06/21 Morgan Stanley American Airlines initiated with an Underweight at Morgan Stanley 03/30/21 Fly Intel: Top five analyst upgrades 03/30/21 Jefferies Jefferies upgrades American Airlines to Hold on outperformance potential 03/30/21 Citi Citi takes 'cautious view' on American Airlines capacity additions AAL American Airlines $22.92 / -0.625 (-2.66%) 07:42 Today American Airlines sees Q1 revenue down 62% from last year 01/28/21 American Airlines reports Q4 adjusted EPS ($3.86), consensus ($4.11) 01/27/21 Notable companies reporting before tomorrow's open 01/27/21 Notable companies reporting before tomorrow's open 10 Nov 23 Jun AAL American Airlines $22.92 / -0.625 (-2.66%) 03/29/21 CDC chief warns of 'impending doom' amid rise in travel, AP reports 03/18/21 Biden administration looks to ease travel restrictions in mid-May, CNBC says 03/05/21 American Air 737 MAX jet declared emergency, lands safely, Reuters says 03/03/21 American, United to give J&J COVID-19 vaccine to Chicago workers, Reuters says AAL American Airlines $22.92 / -0.625 (-2.66%) 04/05/21 Tesla upgrade, GM initiation among today's top calls on Wall Street 03/30/21 Fly Intel: Wall Street's top stories for Tuesday 03/30/21 Alphabet, Roku upgrades among today's top calls on Wall Street 02/22/21 Airbnb, Snap upgrades among today's top calls on Wall Street 04/15/21 Aerospace & Defense 04/22/21 American Airlines - AAL AAL American Airlines $22.92 / -0.625 (-2.66%) 04/05/21 American Airlines call volume above normal and directionally bullish 03/15/21 Early notable gainers among liquid option names on March 15th 03/12/21 American Airlines call volume above normal and directionally bullish 02/24/21 American Airlines call volume above normal and directionally bullish
Recommendations	Netflix investor sentiment 'remains muted' into Q1, says JPMorgan » 07:43 04/13/21 04/13 07:43 04/13/21 07:43 NFLX Netflix $552.89 / -1.84 (-0.33%) JPMorgan analyst Doug… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NFLX Netflix $552.89 / -1.84 (-0.33%) 03/03/21 Netflix launches Fast Laughs feature for mobile devices 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 02/10/21 Netflix says 'Redwall' adaptation in the works 02/01/21 Netflix says Sega's 'Sonic Prime' series coming in 2022 NFLX Netflix $552.89 / -1.84 (-0.33%) 04/09/21 Stifel Stifel sees several factors posing risk to Netflix Q1 results 04/09/21 Benchmark Netflix deal for Sony films 'hardly transformative,' says Benchmark 04/08/21 KeyBanc Netflix, Disney superior retention reinforces scale advantages, says KeyBanc 04/05/21 Evercore ISI Netflix assumed with an Outperform at Evercore ISI NFLX Netflix $552.89 / -1.84 (-0.33%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 01/19/21 Netflix sees Q1 EPS $2.97, consensus $2.10 01/19/21 Netflix reports Q4 EPS $1.19, consensus $1.39 01/19/21 Notable companies reporting after market close NFLX Netflix $552.89 / -1.84 (-0.33%) 04/08/21 Netflix in multi-year movie pact with Sony, including 'Spider-Man', WSJ says 04/01/21 Roku sees spike in viewership, ad spending amid content addition, Engadget says 04/01/21 NBCUniversal considers pulling movies from HBO Max, Netflix, Bloomberg reports 03/13/21 Coupang 'is the Amazon of South Korea,' maybe even better, Barron's says NFLX Netflix $552.89 / -1.84 (-0.33%) 04/08/21 Fly Intel: Wall Street's top stories for Thursday 04/06/21 Roku, Starbucks initiations among today's top calls on Wall Street 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street 03/29/21 Analysts upgrade ViacomCBS, GSX Techedu as selloff in shares continues 04/20/21 Netflix - NFLX NFLX Netflix $552.89 / -1.84 (-0.33%) 04/06/21 Unusually active option classes on open April 6th 03/23/21 Early notable gainers among liquid option names on March 23rd 03/23/21 Unusually active option classes on open March 23rd 02/18/21 $43M premium sale in Netflix suggests quick unwind
Recommendations	Zuora price target raised to $20 from $19 at Canaccord » 07:42 04/13/21 04/13 07:42 04/13/21 07:42 ZUO Zuora $16.48 / +0.045 (+0.27%) Canaccord analyst Joseph… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options ZUO Zuora $16.48 / +0.045 (+0.27%) 04/12/21 Zuora targets subscription revenue growth of 25% or more in FY25 12/08/20 Zuora announce strategic partnership with Stripe 12/08/20 Zuora to partner with Stripe to accelerate growth of 'Subscription Economy' 12/03/20 Zuora reports Q3 customer usage of solutions up 31% at $14.6B ZUO Zuora $16.48 / +0.045 (+0.27%) 04:59 Today Jefferies Zuora market cap could increase to $3B from $2B, says Jefferies 04/08/21 Berenberg Zuora initiated with a Buy at Berenberg 02/24/21 Jefferies Zuora price target raised to $17 from $13 at Jefferies 12/04/20 Canaccord Zuora risk/reward attractive into next year, says Canaccord ZUO Zuora $16.48 / +0.045 (+0.27%) 03/11/21 Zuora sees FY22 EPS (10c) to (6c), consensus (9c) 03/11/21 Zuora sees Q1 EPS (4c) to (3), consensus (4c) 03/11/21 Zuora reports Q4 EPS (2c), consensus (5c) 12/03/20 Zuora sees FY21 EPS (14c) to (13c), consensus (16c) ZUO Zuora $16.48 / +0.045 (+0.27%) 04/12/21 Fly Intel: After-Hours Movers 12/03/20 Fly Intel: After-Hours Movers ZUO Zuora $16.48 / +0.045 (+0.27%) 12/28/20 Zuora call volume above normal and directionally bullish
Initiation	Black Knight initiated with a Market Perform at Raymond James » 07:42 04/13/21 04/13 07:42 04/13/21 07:42 BKI Black Knight $74.30 / -0.58 (-0.77%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events BKI Black Knight $74.30 / -0.58 (-0.77%) 03/17/21 Black Knight acquires cloud-based loan origination system from NexSpring 02/22/21 Black Knight announces expansion of relationship with The Money Source 11/13/20 Third Point takes stake in PG&E, boosts Alibaba stake, exits Baxter 11/09/20 Black Knight sees FY20 adjusted EPS $2.03-$2.07, consensus $1.98 BKI Black Knight $74.30 / -0.58 (-0.77%) 02/17/21 Susquehanna Susquehanna upgrades Black Knight to Positive as growth resumes 02/17/21 Susquehanna Black Knight upgraded to Positive from Neutral at Susquehanna 01/05/21 Barclays Black Knight price target raised to $105 from $103 at Barclays 12/14/20 Jefferies Black Knight initiated with a Buy at Jefferies BKI Black Knight $74.30 / -0.58 (-0.77%) 02/16/21 Black Knight sees FY21 $2.11-$2.22, consensus $2.35 02/16/21 Black Knight reports Q4 adjusted EPS 60c, consensus 55c 11/09/20 Black Knight reports Q3 adjusted EPS 52c, consensus 49c 17 Jun 05/24/21 Global Technology, Media & Communications Virtual Conference

Hot Stocks	GeoPark reports Q1 consolidated oil, gas production of 38,131 boepd » 07:42 04/13/21 04/13 07:42 04/13/21 07:42 GPRK GeoPark $15.70 / -0.0999 (-0.63%) GeoPark announced its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research GPRK GeoPark $15.70 / -0.0999 (-0.63%) 01/07/21 GeoPark announces Q4 operational update 12/21/20 GeoPark falls -11.3% 11/23/20 GeoPark to sell its 10% WI in Manati gas field in Brazil to Gas Bridge for $27M 10/14/20 GeoPark says overall oil and gas productiion down 2% in Q3 to 38,845 boepd GPRK GeoPark $15.70 / -0.0999 (-0.63%) 03/11/21 BMO Capital GeoPark price target raised to $20 from $15 at BMO Capital 09/24/20 JPMorgan GeoPark initiated with an Overweight at JPMorgan 06/25/20 Bradesco BBI GeoPark initiated with an Outperform at Bradesco BBI 06/03/20 Eight Capital GeoPark upgraded to Buy from Neutral at Eight Capital
Earnings	American Airlines sees Q1 revenue down 62% from last year » 07:42 04/13/21 04/13 07:42 04/13/21 07:42 AAL American Airlines $22.92 / -0.625 (-2.66%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options AAL American Airlines $22.92 / -0.625 (-2.66%) 04/05/21 CDC issues updated guidance on travel for fully vaccinated people 03/31/21 American Airlines repays $2.8B in revolving loans related to COVID 03/29/21 American Airlines now sees Q1 system capacity down 40%-45%, up from prior view 03/08/21 American Airlines announces proposed offering of senior secured notes AAL American Airlines $22.92 / -0.625 (-2.66%) 04/06/21 Morgan Stanley American Airlines initiated with an Underweight at Morgan Stanley 03/30/21 Fly Intel: Top five analyst upgrades 03/30/21 Jefferies Jefferies upgrades American Airlines to Hold on outperformance potential 03/30/21 Citi Citi takes 'cautious view' on American Airlines capacity additions AAL American Airlines $22.92 / -0.625 (-2.66%) 01/28/21 American Airlines reports Q4 adjusted EPS ($3.86), consensus ($4.11) 01/27/21 Notable companies reporting before tomorrow's open 01/27/21 Notable companies reporting before tomorrow's open 10/22/20 American Airlines reports Q3 EPS ex-items ($5.54), consensus ($5.88) 10 Nov 23 Jun AAL American Airlines $22.92 / -0.625 (-2.66%) 03/29/21 CDC chief warns of 'impending doom' amid rise in travel, AP reports 03/18/21 Biden administration looks to ease travel restrictions in mid-May, CNBC says 03/05/21 American Air 737 MAX jet declared emergency, lands safely, Reuters says 03/03/21 American, United to give J&J COVID-19 vaccine to Chicago workers, Reuters says AAL American Airlines $22.92 / -0.625 (-2.66%) 04/05/21 Tesla upgrade, GM initiation among today's top calls on Wall Street 03/30/21 Fly Intel: Wall Street's top stories for Tuesday 03/30/21 Alphabet, Roku upgrades among today's top calls on Wall Street 02/22/21 Airbnb, Snap upgrades among today's top calls on Wall Street 04/15/21 Aerospace & Defense 04/22/21 American Airlines - AAL AAL American Airlines $22.92 / -0.625 (-2.66%) 04/05/21 American Airlines call volume above normal and directionally bullish 03/15/21 Early notable gainers among liquid option names on March 15th 03/12/21 American Airlines call volume above normal and directionally bullish 02/24/21 American Airlines call volume above normal and directionally bullish
Hot Stocks	Novocure: DMC recommends continuation of LUNAR trial » 07:40 04/13/21 04/13 07:40 04/13/21 07:40 NVCR Novocure $131.91 / -0.1 (-0.08%) , ZLAB Zai Lab $132.00 / -0.84 (-0.63%) Zai Lab Limited (ZLAB)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events NVCR ZLAB NVCR Novocure $131.91 / -0.1 (-0.08%) 12/14/20 Novocure announces BAG to add Optune combination to MiGeL 12/10/20 Novocure enrolls 1st patient in global phase 3 TRIDENT trial 11/11/20 Novocure receives CE Mark for NovoTTF-100L system 10/29/20 Novocure forms alliance with NYU Grossman School of Medicine ZLAB Zai Lab $132.00 / -0.84 (-0.63%) 03/31/21 Zai Lab, Deciphera announce China NMPA approval of Qinlock NDA 01/11/21 Turning Point Therapeutics, Zai Lab expand collaboration to include TPX-0022 01/08/21 Argenx expects 2021 cash burn 'approximately doubling' compared to 2020 01/08/21 Argenx announces submission of BLA to FDA for efgartigimod in gMG treatment NVCR ZLAB NVCR Novocure $131.91 / -0.1 (-0.08%) 03/01/21 Mizuho Novocure price target raised to $175 from $150 at Mizuho 02/25/21 Piper Sandler 'Overreaction to downside' in Novocure a buying opportunity, says Piper Sandler 01/29/21 Truist Novocure price target raised to $132 from $118 at Truist 01/25/21 Piper Sandler Novocure price target raised to $225 from $140 at Piper Sandler ZLAB Zai Lab $132.00 / -0.84 (-0.63%) 02/08/21 Jefferies Zai Lab price target raised to $225 upon assumption at Jefferies 01/15/21 Citi Citi boosts Zai Lab target to $216, adds to U.S. Focus List 01/07/21 Wedbush Argenx price target raised to $293 from $283 at Wedbush 11/16/20 JPMorgan Zai Lab price target raised to $111 from $101 at JPMorgan NVCR ZLAB NVCR Novocure $131.91 / -0.1 (-0.08%) 02/25/21 Novocure reports Q4 EPS 4c, consensus 12c 01/11/21 Novocure sees FY20 revenue $494.4M, consensus $482.29M 01/11/21 Novocure sees Q4 revenue $144M, consensus $133.26M 10/29/20 Novocure reports Q3 EPS 9c, consensus 3c ZLAB Zai Lab $132.00 / -0.84 (-0.63%) 03/01/21 Zai Lab reports 2020 EPS ($3.46) vs. ($3.03) last year 04/29/21 Novocure - NVCR
Recommendations	Starbucks price target raised to $132 from $116 at Argus » 07:39 04/13/21 04/13 07:39 04/13/21 07:39 SBUX Starbucks $113.81 / +0.64 (+0.57%) Argus analyst John … Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SBUX Starbucks $113.81 / +0.64 (+0.57%) 03/30/21 Bakkt launches Bakkt App digital wallet 03/17/21 Starbucks says balance sheet remains strong 03/17/21 Starbucks plans to make its green coffee carbon neutral by 2030 03/17/21 Starbucks CEO says 'encouraging,' but not requiring, employees to get vaccinated SBUX Starbucks $113.81 / +0.64 (+0.57%) 04/12/21 JPMorgan Starbucks price target raised to $104 from $97 at JPMorgan 04/06/21 Fly Intel: Top five analyst initiations 04/06/21 Atlantic Equities Starbucks initiated with an Overweight at Atlantic Equities 03/19/21 Fly Intel: Top five analyst upgrades SBUX Starbucks $113.81 / +0.64 (+0.57%) 01/26/21 Starbucks sees January U.S. SSS down 2% 01/26/21 Starbucks backs FY21 revenue view of $28.0B-$29.0B, consensus $28.5B 01/26/21 Starbucks backs FY21 EPS $2.70-$2.90, consensus $2.81 01/26/21 Starbucks sees Q2 EPS 45c-50c, consensus 59c SBUX Starbucks $113.81 / +0.64 (+0.57%) 04/06/21 Starbucks to discontinue single-use cups in South Korea by 2025, CNBC reports 03/31/21 Starbucks strikes deal with EEOC over alleged racial bias, CNBC reports 03/18/21 Starbucks investors rejects proposal on executive pay, WSJ reports 01/26/21 Walgreens Boots Alliance set to name Starbucks COO Roz Brewer as CEO, WSJ says SBUX Starbucks $113.81 / +0.64 (+0.57%) 04/06/21 Roku, Starbucks initiations among today's top calls on Wall Street 03/19/21 Molson Coors downgrade, Starbucks upgrade among today's top calls on Wall Street 03/16/21 Starbucks upgrade, Ulta downgrade among today's top calls on Wall Street 02/23/21 Starbucks upgrade, Kroger downgrade among today's top calls on Wall Street SBUX Starbucks $113.81 / +0.64 (+0.57%) 03/17/21 Unusually active option classes on open March 17th 02/05/21 Starbucks call volume above normal and directionally bullish 01/26/21 Starbucks options imply 6.1% move in share price post-earnings 12/10/20 Early notable gainers among liquid option names on December 10th
Hot Stocks	Blade Urban Air Mobility to secure up to 20 ALIA Electric Vertical Aircraft » 07:39 04/13/21 04/13 07:39 04/13/21 07:39 EXPC Experience Investment Corp. $10.33 / -0.06 (-0.58%) Blade Urban Air Mobility… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Options EXPC Experience Investment Corp. $10.33 / -0.06 (-0.58%) 12/28/20 Hedgeye adds Experience Investment Corp. to Best Idea Long list, Bloomberg says EXPC Experience Investment Corp. $10.33 / -0.06 (-0.58%) 02/03/21 new option listings on February 3rd

Hot Stocks	Gaming and Leisure Properties to acquire some of Bally's assets for $150M » 07:39 04/13/21 04/13 07:39 04/13/21 07:39 GLPI Gaming and Leisure Properties $43.37 / +0.11 (+0.25%) , BALY Bally's $60.79 / -0.885 (-1.43%) , PENN Penn National $101.84 / -2.33 (-2.24%) Gaming and Leisure… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options GLPI BALY PENN GLPI Gaming and Leisure Properties $43.37 / +0.11 (+0.25%) 07:05 Today Bally's to acquire Tropicana Las Vegas from Gaming and Leisure Properties 01/07/21 Gaming and Leisure Properties promotes Steven Ladany to CDO 01/05/21 Gaming and Leisure Properties appoints Matthew Demchyk to CIO 12/15/20 Penn National to acquire Hollywood Casino Perryville from GLPI for $31.1M BALY Bally's $60.79 / -0.885 (-1.43%) 07:05 Today Bally's to acquire Tropicana Las Vegas from Gaming and Leisure Properties 05:26 Today Bally's to combine with Gamesys Group 04/12/21 Bally's announces agreement with Sinclair Broadcast 03/25/21 Allied Esports Entertainment determines Bally's proposal superior to Element's PENN Penn National $101.84 / -2.33 (-2.24%) 04/07/21 New York state budget for fiscal 2022 legalizes mobile sports betting 04/06/21 Dave Portnoy tweets regarding decline in Penn National shares 03/26/21 PointsBet extends online gaming services framework agreement with Penn National 03/25/21 Nevada reports statewide February gaming win down 26% to $772.41M GLPI BALY PENN GLPI Gaming and Leisure Properties $43.37 / +0.11 (+0.25%) 03/31/21 Mizuho Gaming and Leisure Properties initiated with a Buy at Mizuho 03/15/21 Fly Intel: Top five analyst initiations 03/15/21 KeyBanc Gaming and Leisure Properties initiated with an Overweight at KeyBanc 02/22/21 Deutsche Bank Gaming and Leisure Properties price target raised to $51 from $48 at Deutsche Bank BALY Bally's $60.79 / -0.885 (-1.43%) 04/08/21 KeyBanc Bally's price target raised to $70 from $65 at KeyBanc 03/29/21 Truist Early March casino data looks 'very positive,' says Truist 03/25/21 Stifel Bally's price target raised to $75 from $70 at Stifel 03/24/21 Jefferies Gamesys Group and Bally's an 'interesting combination,' says Jefferies PENN Penn National $101.84 / -2.33 (-2.24%) 04/07/21 Truist Truist sees NY budget agreement's mobile sports betting deal as 'clear as mud' 04/06/21 Credit Suisse Reports, contacts point to sports betting momentum in NY, Credit Suisse says 04/01/21 Credit Suisse NY online sports betting likely to make it into budget, says Credit Suisse 03/29/21 Deutsche Bank New York may be 'kicking the can' on sports betting, says Deutsche GLPI BALY PENN GLPI Gaming and Leisure Properties $43.37 / +0.11 (+0.25%) 02/18/21 Gaming and Leisure Properties reports Q4 FFO 85c, consensus 85c 10/27/20 Gaming and Leisure Propertiesl Partners reports Q3 FFO 89c, consensus 85c BALY Bally's $60.79 / -0.885 (-1.43%) 07:03 Today Bally's sees Q1 revenue $185M, consensus $156.45M 03/04/21 Bally's reports Q4 adjusted EPS 39c, consensus (8c) 11/09/20 Bally's Corporation changes name from Twin River Worldwide Holdings PENN Penn National $101.84 / -2.33 (-2.24%) 02/04/21 Penn National reports Q4 EPS 7c, consensus 24c 02/03/21 Notable companies reporting before tomorrow's open 02/03/21 Notable companies reporting before tomorrow's open 10/29/20 Penn National reports Q3 EPS 93c, consensus 53c 30 Oct 25 Sep 12 May BALY PENN BALY Bally's $60.79 / -0.885 (-1.43%) 03/10/21 Casino companies prepare to compete for NYC-area license, NY Post reports 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says PENN Penn National $101.84 / -2.33 (-2.24%) 04/06/21 New York to approve online sports betting model backed by Cuomo, Action says 02/12/21 Nevada to roll back capacity restrictions on casinos, Reno Gazette Journal says 02/09/21 TX Lt. Gov. sees no support for legalized sports betting, Houston Chronicle says 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says BALY PENN BALY Bally's $60.79 / -0.885 (-1.43%) 04/09/21 Bet On It: Mobile sports betting added to budget in New York 04/01/21 Bet On It: Sports betting operators make more content-related deals 03/26/21 Bet On It: Las Vegas recovery potentially underway as restrictions loosen 03/24/21 Fly Intel: Wall Street's top stories for Wednesday PENN Penn National $101.84 / -2.33 (-2.24%) 04/09/21 Bet On It: Mobile sports betting added to budget in New York 04/01/21 Bet On It: Sports betting operators make more content-related deals 03/26/21 Bet On It: Las Vegas recovery potentially underway as restrictions loosen 03/19/21 Bet On It: Connecticut governor, two tribes in agreement on sports betting 04/30/21 Gaming and Leisure Properties - GLPI 05/06/21 Penn National - PENN 05/18/21 Bally's Corporation PENN PENN Penn National $101.84 / -2.33 (-2.24%) 03/01/21 Unusually active option classes on open March 1st 01/12/21 Penn National call volume above normal and directionally bullish 12/16/20 Penn National call volume above normal and directionally bullish 12/14/20 Penn National call volume above normal and directionally bullish
Hot Stocks	Partner Communications rejects offers for 20% of company's fiber optic rights » 07:38 04/13/21 04/13 07:38 04/13/21 07:38 PTNR Partner Communications $4.63 / -0.03 (-0.64%) Partner Communications… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research PTNR Partner Communications $4.63 / -0.03 (-0.64%) 01/18/21 Partner says lawsuit against subsidiary recognized as class action 11/18/20 Partner Communications announces consideration of fiber optics transaction PTNR Partner Communications $4.63 / -0.03 (-0.64%) 12/02/20 Barclays Partner Communications price target raised to ILS 1,900 at Barclays
Hot Stocks	BridgeBio announces collaboration agreement with OHSU » 07:38 04/13/21 04/13 07:38 04/13/21 07:38 BBIO BridgeBio $53.97 / -0.51 (-0.94%) BridgeBio Pharma… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals BBIO BridgeBio $53.97 / -0.51 (-0.94%) 07:36 Today BridgeBio announces collaboration agreement with The Lundquist Institute 07:33 Today BridgeBio announces formal collaboration with Brown University 03/31/21 BridgeBio's QED, Helsinn Group collaborate to co-develop infigratinib 03/21/21 BridgeBio announces proof-of-concept data of Encaleret in ADH1 BBIO BridgeBio $53.97 / -0.51 (-0.94%) 03/22/21 Goldman Sachs BridgeBio price target raised to $91 from $83 at Goldman Sachs 03/22/21 Piper Sandler BridgeBio's encaleret likely to be new standard of care, says Piper Sandler 03/04/21 Mizuho BridgeBio price target raised to $86 from $56 at Mizuho 03/01/21 Piper Sandler BridgeBio's first approval small but significant, says Piper Sandler BBIO BridgeBio $53.97 / -0.51 (-0.94%) 02/25/21 BridgeBio reports Q4 EPS ($1.01), consensus (85c) 11/05/20 BridgeBio reports Q3 EPS (98c), consensus (92c) 12 Feb 29 May BBIO BridgeBio $53.97 / -0.51 (-0.94%) 12/11/20 GlaxoSmithKline offered $120 per share for Eidos Therapeutics, Bloomberg says
Recommendations	Microsoft price target raised to $300 from $275 at Argus » 07:37 04/13/21 04/13 07:37 04/13/21 07:37 MSFT Microsoft $255.89 / +0.16 (+0.06%) , NUAN Nuance $52.80 / +7.21 (+15.81%) Argus analyst Joseph… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MSFT NUAN MSFT Microsoft $255.89 / +0.16 (+0.06%) 04/12/21 Nuance jumps 23% to $56.00 after Microsoft confirms takeover bid 04/12/21 Microsoft to acquire Nuance for $56.00 per share in cash, or $19.7B 04/12/21 Microsoft to acquire Nuance for $56.00 per share in cash 04/12/21 Unisys names Dwayne Allen as Chief Technology Officer NUAN Nuance $52.80 / +7.21 (+15.81%) 04/12/21 Nuance trading resumes 04/12/21 Nuance to resume trading at 09:00ET 04/12/21 Nuance jumps 23% to $56.00 after Microsoft confirms takeover bid 04/12/21 Microsoft to acquire Nuance for $56.00 per share in cash, or $19.7B MSFT NUAN MSFT Microsoft $255.89 / +0.16 (+0.06%) 06:57 Today BMO Capital BMO Capital positive on Microsoft deal for Nuance 04/12/21 Jefferies Microsoft deal emphasizes healthcare cloud focus, says Jefferies 04/12/21 Stifel Microsoft a 'logical buyer' of Nuance, says Stifel 04/12/21 B. Riley Nuance possible takeout positive for peer LivePerson, says B. Riley NUAN Nuance $52.80 / +7.21 (+15.81%) 06:57 Today BMO Capital BMO Capital positive on Microsoft deal for Nuance 06:22 Today Wedbush Nuance downgraded to Neutral from Outperform at Wedbush 04/12/21 Jefferies Microsoft deal emphasizes healthcare cloud focus, says Jefferies 04/12/21 Stifel Microsoft a 'logical buyer' of Nuance, says Stifel MSFT NUAN MSFT Microsoft $255.89 / +0.16 (+0.06%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 01/26/21 Microsoft reports Q2 EPS $2.03, consensus $1.64 01/26/21 Notable companies reporting after market close 10/27/20 Microsoft sees Q2 Productivity and Business Processes revenue $12.75B-$13B NUAN Nuance $52.80 / +7.21 (+15.81%) 02/08/21 Nuance raises FY21 revenue view to $1.34B-$1.38B from $1.33B-$1.37B 02/08/21 Nuance sees Q2 EPS 14c-18c, consensus 18c 02/08/21 Nuance reports Q1 adjusted EPS 20c, consensus 18c 11/18/20 Nuance says FY21 guidance reflects continuing Enterprise revenue growth MSFT NUAN MSFT Microsoft $255.89 / +0.16 (+0.06%) 04/11/21 Microsoft in talks to buy Nuance for about $56 per share, Bloomberg says 04/09/21 Hackers scraped data of 500M LinkedIn users, Insider reports 04/06/21 Facebook, Apple and Niantic see a future in augmented -reality glasses, WSJ says 04/01/21 LinkedIn testing Clubhouse competitor, Business Insider reports NUAN Nuance $52.80 / +7.21 (+15.81%) 04/11/21 Microsoft in talks to buy Nuance for about $56 per share, Bloomberg says MSFT NUAN MSFT Microsoft $255.89 / +0.16 (+0.06%) 04/12/21 Fly Intel: Wall Street's top stories for Monday 04/12/21 Fly Intel: Wall Street's top stories at midday 04/12/21 Fly Intel: Pre-market Movers 04/07/21 Game On: An exclusive talk with 'Genesis Noir' developer Feral Cat Den NUAN Nuance $52.80 / +7.21 (+15.81%) 04/12/21 Fly Intel: Wall Street's top stories for Monday 04/12/21 Fly Intel: Wall Street's top stories at midday 04/12/21 Fly Intel: Pre-market Movers 03/08/21 Microsoft, Salesforce rise as analysts get more bullish on software sector 05/24/21 Global Technology, Media & Communications Virtual Conference MSFT NUAN MSFT Microsoft $255.89 / +0.16 (+0.06%) 04/06/21 Microsoft call buyer realizes 130% same-day gains 01/26/21 Microsoft options imply 6.7% move in share price post-earnings 12/17/20 Notable open interest changes for December 17th 11/11/20 Notable open interest changes for November 11th NUAN Nuance $52.80 / +7.21 (+15.81%) 07:35 Today Unusual call flow in option market yesterday 04/07/21 Nuance call volume above normal and directionally bullish 03/23/21 Nuance call buyer realizes 9% same-day gains 02/08/21 Nuance options imply 10.5% move in share price post-earnings
Hot Stocks	BridgeBio announces collaboration agreement with The Lundquist Institute » 07:36 04/13/21 04/13 07:36 04/13/21 07:36 BBIO BridgeBio $53.97 / -0.51 (-0.94%) BridgeBio Pharma and The… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals BBIO BridgeBio $53.97 / -0.51 (-0.94%) 07:33 Today BridgeBio announces formal collaboration with Brown University 03/31/21 BridgeBio's QED, Helsinn Group collaborate to co-develop infigratinib 03/21/21 BridgeBio announces proof-of-concept data of Encaleret in ADH1 02/28/21 BridgeBio, affiliate Origin Biosciences announce FDA approval of NULIBRY BBIO BridgeBio $53.97 / -0.51 (-0.94%) 03/22/21 Goldman Sachs BridgeBio price target raised to $91 from $83 at Goldman Sachs 03/22/21 Piper Sandler BridgeBio's encaleret likely to be new standard of care, says Piper Sandler 03/04/21 Mizuho BridgeBio price target raised to $86 from $56 at Mizuho 03/01/21 Piper Sandler BridgeBio's first approval small but significant, says Piper Sandler BBIO BridgeBio $53.97 / -0.51 (-0.94%) 02/25/21 BridgeBio reports Q4 EPS ($1.01), consensus (85c) 11/05/20 BridgeBio reports Q3 EPS (98c), consensus (92c) 12 Feb 29 May BBIO BridgeBio $53.97 / -0.51 (-0.94%) 12/11/20 GlaxoSmithKline offered $120 per share for Eidos Therapeutics, Bloomberg says

Initiation	Cowen starts Instil Bio at Outperform on 'second-mover advantage' » 07:36 04/13/21 04/13 07:36 04/13/21 07:36 TIL Instil Bio $22.13 / +0.05 (+0.23%) , IOVA Iovance Biotherapeutics $29.41 / -0.74 (-2.45%) Cowen analyst Yaron… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly TIL IOVA TIL Instil Bio $22.13 / +0.05 (+0.23%) 04/12/21 Instil Bio presents clinical data for metastatic melanoma at 2021 AACR meeting IOVA Iovance Biotherapeutics $29.41 / -0.74 (-2.45%) 04/09/21 Iovance Biotherapeutics announces clinical data updates for Lifileucel 03/15/21 Iovance Biotherapeutics appoints Igor Bilinsky as COO 12/14/20 Iovance Biotherapeutics appoints Jean-Marc Bellemin as CFO 11/09/20 Iovance Biotherapeutics presents interim data for LN-145 w/ pembrolizumab TIL IOVA TIL Instil Bio $22.13 / +0.05 (+0.23%) 07:07 Today Truist Truist starts Instil Bio with a Buy citing efficacy in solid tumors 06:18 Today Truist Instil Bio initiated with a Buy at Truist 06:00 Today Cowen Instil Bio initiated with an Outperform at Cowen 05:59 Today Morgan Stanley Instil Bio initiated with an Equal Weight at Morgan Stanley IOVA Iovance Biotherapeutics $29.41 / -0.74 (-2.45%) 03/08/21 H.C. Wainwright Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright 01/29/21 Baird Iovance Biotherapeutics assumed at Outperform at Baird 01/14/21 Oppenheimer Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer 12/17/20 Barclays Iovance Biotherapeutics price target raised to $55 from $43 at Barclays IOVA IOVA Iovance Biotherapeutics $29.41 / -0.74 (-2.45%) 02/25/21 Iovance Biotherapeutics reports Q4 EPS (47c), consensus (44c) 19 Mar 29 May TIL TIL Instil Bio $22.13 / +0.05 (+0.23%) 03/20/21 Opening Day: China's Tuya raised $915M in U.S. IPO
Options	Unusual call flow in option market yesterday » 07:35 04/13/21 04/13 07:35 04/13/21 07:35 NUAN Nuance $52.80 / +7.21 (+15.81%) , VVV Valvoline $26.90 / +0.405 (+1.53%) Notable call activity was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NUAN VVV NUAN Nuance $52.80 / +7.21 (+15.81%) 04/12/21 Nuance trading resumes 04/12/21 Nuance to resume trading at 09:00ET 04/12/21 Nuance jumps 23% to $56.00 after Microsoft confirms takeover bid 04/12/21 Microsoft to acquire Nuance for $56.00 per share in cash, or $19.7B VVV Valvoline $26.90 / +0.405 (+1.53%) 12/02/20 Valvoline to acquire 27 quick-lube locations in seven states 11/12/20 Valvoline announces $100M share repurchase 11/12/20 Valvoline raises quarterly dividend to 12.5c per share from 11.25c 11/10/20 Monro announces renewed supply agreement with Valvoline NUAN VVV NUAN Nuance $52.80 / +7.21 (+15.81%) 06:57 Today BMO Capital BMO Capital positive on Microsoft deal for Nuance 06:22 Today Wedbush Nuance downgraded to Neutral from Outperform at Wedbush 04/12/21 Jefferies Microsoft deal emphasizes healthcare cloud focus, says Jefferies 04/12/21 Stifel Microsoft a 'logical buyer' of Nuance, says Stifel VVV Valvoline $26.90 / +0.405 (+1.53%) 03/22/21 Citi Valvoline price target raised to $32 from $28 at Citi 02/08/21 Citi Valvoline price target raised to $28 from $25 at Citi 02/04/21 Monness Crespi Valvoline price target raised to $30 from $26 at Monness Crespi 01/11/21 Seaport Global Valvoline downgraded to Neutral from Buy at Seaport Global NUAN VVV NUAN Nuance $52.80 / +7.21 (+15.81%) 02/08/21 Nuance raises FY21 revenue view to $1.34B-$1.38B from $1.33B-$1.37B 02/08/21 Nuance sees Q2 EPS 14c-18c, consensus 18c 02/08/21 Nuance reports Q1 adjusted EPS 20c, consensus 18c 11/18/20 Nuance says FY21 guidance reflects continuing Enterprise revenue growth VVV Valvoline $26.90 / +0.405 (+1.53%) 02/03/21 Valvoline still sees FY21 adjusted EPS $1.57-$1.67, consensus $1.64 02/03/21 Valvoline reports Q1 adjusted EPS 41c, consensus 36c 10/28/20 Valvoline reports Q4 adjusted EPS 46c, consensus 36c NUAN NUAN Nuance $52.80 / +7.21 (+15.81%) 04/11/21 Microsoft in talks to buy Nuance for about $56 per share, Bloomberg says NUAN NUAN Nuance $52.80 / +7.21 (+15.81%) 04/12/21 Fly Intel: Wall Street's top stories for Monday 04/12/21 Fly Intel: Wall Street's top stories at midday 04/12/21 Fly Intel: Pre-market Movers 03/08/21 Microsoft, Salesforce rise as analysts get more bullish on software sector NUAN VVV NUAN Nuance $52.80 / +7.21 (+15.81%) 04/07/21 Nuance call volume above normal and directionally bullish 03/23/21 Nuance call buyer realizes 9% same-day gains 02/08/21 Nuance options imply 10.5% move in share price post-earnings VVV Valvoline $26.90 / +0.405 (+1.53%) 04/12/21 Call buyer slides into Valvoline position vs 50k share delta hedge
Hot Stocks	Axcella announces AXA1125's IND clearance for the treatment of NASH » 07:34 04/13/21 04/13 07:34 04/13/21 07:34 AXLA Axcella Health $4.24 / -0.09 (-2.08%) Axcella announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events AXLA Axcella Health $4.24 / -0.09 (-2.08%) 03/03/21 Axcella Health names Alison Schecter as President of R&D 01/11/21 Axcella announces IND clearance for AXA1665, program updates AXLA Axcella Health $4.24 / -0.09 (-2.08%) 03/22/21 Wedbush Axcella Health price target lowered to $11 from $19 at Wedbush 03/18/21 Chardan Axcella Health moving forward with two lead programs, says Chardan 11/18/20 Roth Capital Axcella Health initiated with a Buy at Roth Capital 10/27/20 Fly Intel: Top five analyst initiations AXLA Axcella Health $4.24 / -0.09 (-2.08%) 03/17/21 Axcella Health reports Q4 EPS (40c), consensus (36c) 11/12/20 Axcella Health reports Q3 EPS (34c), consensus (41c) 14 May AXLA Axcella Health $4.24 / -0.09 (-2.08%) 11/12/20 Fly Intel: Pre-market Movers 05/20/21 Axcella Health Inc.
Hot Stocks	Aleafia Health introduces wellness brand Noon & Night » 07:34 04/13/21 04/13 07:34 04/13/21 07:34 ALEAF Aleafia Health / + Aleafia Health announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ALEAF Aleafia Health / + 04/07/21 Aleafia Health launches Divvy cannabis brand 03/16/21 Aleafia Health enters Saskatchewan adult-use market 03/02/21 Aleafia Health launches cannabis soft chews by Bogart's Kitchen 02/16/21 Aleafia Health secures licence for Toronto Distribution Centre ALEAF Aleafia Health / + 03/10/21 Cantor Fitzgerald Aleafia Health initiated with a Neutral at Cantor Fitzgerald ALEAF Aleafia Health / + 03/25/21 Aleafia Health reports Q4 revenue C$15.2M vs. C$6.03M last year 11/11/20 Aleafia Health reports Q3 revenue $4.97M vs. $4.96M last year ALEAF Aleafia Health / + 11/12/20 Rising High: Cannabis companies report earnings
Hot Stocks	Geron announces first patient dosed in IMpactMF trial » 07:34 04/13/21 04/13 07:34 04/13/21 07:34 GERN Geron $1.41 / -0.075 (-5.05%) Geron announced that the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events GERN Geron $1.41 / -0.075 (-5.05%) 03/11/21 Geron sees FY21 operating expense burn $108M-$112M 12/11/20 Geron opens patient screening, enrollment for IMpactMF trial 12/10/20 Geron achieves 50% enrollment in IMerge Phase 3 clinical trial of imetelstat 10/28/20 Geron discloses safety and efficacy data of IMerge ph2 trial published in JCO GERN Geron $1.41 / -0.075 (-5.05%) 02/18/21 B. Riley Securities Geron transferred with Buy rating at B. Riley Securities 10/14/20 B. Riley Securities Geron shares have 100% potential upside, says B. Riley Securities 08/26/20 H.C. Wainwright Geron price target raised to $7 from $4 at H.C. Wainwright 08/03/20 Fly Intel: Top five analyst initiations GERN Geron $1.41 / -0.075 (-5.05%) 03/11/21 Geron reports Q4 EPS (7c), consensus (6c) 11/05/20 Geron reports Q3 EPS (6c), consensus (6c) 22 May 05/11/21 Geron Corporation

Recommendations	Mattel price target raised to $22 from $19.50 at Stifel » 07:33 04/13/21 04/13 07:33 04/13/21 07:33 MAT Mattel $20.28 / +0.15 (+0.75%) , HAS Hasbro $97.12 / +1.875 (+1.97%) Stifel analyst Drew Crum… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MAT HAS MAT Mattel $20.28 / +0.15 (+0.75%) 03/14/21 Fly Intel: Top five weekend stock stories 02/10/21 Mattel CEO: This was an exceptional quarter 02/09/21 Mattel implementing new 'Optimizing for Growth' program 12/08/20 Mattel names Jonathan Anschell chief legal officer HAS Hasbro $97.12 / +1.875 (+1.97%) 03/25/21 Hasbro's 'Magic: The Gathering Arena' now available on mobile devices 02/25/21 Hasbro sees returning to growth in revenues, earnings, EBITDA in 2021 02/08/21 Hasbro CEO: We are on strong footing to grow in 2021 02/08/21 Hasbro CFO: 2021 is starting with strong year-over-year momentum MAT HAS MAT Mattel $20.28 / +0.15 (+0.75%) 02/25/21 Fly Intel: Top five analyst upgrades 02/25/21 Monness Crespi Mattel upgraded to Buy on favorable risk/reward at Monness Crespi 02/25/21 Monness Crespi Mattel upgraded to Buy from Neutral at Monness Crespi 02/25/21 JPMorgan Mattel price target raised to $27 from $22 at JPMorgan HAS Hasbro $97.12 / +1.875 (+1.97%) 03/29/21 MKM Partners Hasbro reached 'important milestones' in videogame business, says MKM Partners 03/15/21 Truist Hasbro price target raised to $100 from $95 at Truist 02/09/21 DA Davidson Hasbro price target raised to $115 from $105 at DA Davidson 02/09/21 BMO Capital Hasbro price target lowered to $85 from $90 at BMO Capital MAT HAS MAT Mattel $20.28 / +0.15 (+0.75%) 02/09/21 Mattel sees FY21 adjusted EBITDA $775M-$800M vs. $719M last year 02/09/21 Mattel reports Q4 adjusted EPS 40c, consensus 23c 02/09/21 Notable companies reporting after market close 10/22/20 Mattel sees 'strong' adjusted EBITDA growth for FY20 vs. FY19 HAS Hasbro $97.12 / +1.875 (+1.97%) 02/08/21 Hasbro reports Q4 adjusted EPS $1.27, consensus $1.14 10/26/20 Hasbro reports Q3 adjusted EPS $1.88, consensus $1.62 MAT MAT Mattel $20.28 / +0.15 (+0.75%) 03/13/21 Retro stocks suddenly hot, Barron's says 03/05/21 Reddit hires Drew Vollero as CFO ahead of eventual IPO, NY Times reports MAT HAS MAT Mattel $20.28 / +0.15 (+0.75%) 02/16/21 American Express downgrade among today's top calls on Wall Street 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday 02/09/21 Fly Intel: After-Hours Movers HAS Hasbro $97.12 / +1.875 (+1.97%) 02/08/21 Fly Intel: Wall Street's top stories for Monday 02/08/21 Fly Intel: Wall Street's top stories at midday 02/08/21 Fly Intel: Pre-market Movers 12/02/20 Verizon upgrade, Salesforce downgrade among today's top calls on Wall Street 05/24/21 Global Technology, Media & Communications Virtual Conference 04/22/21 Mattel - MAT 04/27/21 Hasbro - HAS 05/20/21 Hasbro Inc MAT MAT Mattel $20.28 / +0.15 (+0.75%) 10/23/20 Early notable gainers among liquid option names on October 23rd 10/22/20 Mattel options imply 12.0% move in share price post-earnings 10/21/20 Mattel put volume heavy and directionally bearish
Hot Stocks	BridgeBio announces formal collaboration with Brown University » 07:33 04/13/21 04/13 07:33 04/13/21 07:33 BBIO BridgeBio $53.97 / -0.51 (-0.94%) BridgeBio Pharma and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals BBIO BridgeBio $53.97 / -0.51 (-0.94%) 03/31/21 BridgeBio's QED, Helsinn Group collaborate to co-develop infigratinib 03/21/21 BridgeBio announces proof-of-concept data of Encaleret in ADH1 02/28/21 BridgeBio, affiliate Origin Biosciences announce FDA approval of NULIBRY 02/19/21 BridgeBio, ML Bio Solutions dose first patient in Phase 2 trial of BBP-418 BBIO BridgeBio $53.97 / -0.51 (-0.94%) 03/22/21 Goldman Sachs BridgeBio price target raised to $91 from $83 at Goldman Sachs 03/22/21 Piper Sandler BridgeBio's encaleret likely to be new standard of care, says Piper Sandler 03/04/21 Mizuho BridgeBio price target raised to $86 from $56 at Mizuho 03/01/21 Piper Sandler BridgeBio's first approval small but significant, says Piper Sandler BBIO BridgeBio $53.97 / -0.51 (-0.94%) 02/25/21 BridgeBio reports Q4 EPS ($1.01), consensus (85c) 11/05/20 BridgeBio reports Q3 EPS (98c), consensus (92c) 12 Feb 29 May BBIO BridgeBio $53.97 / -0.51 (-0.94%) 12/11/20 GlaxoSmithKline offered $120 per share for Eidos Therapeutics, Bloomberg says
Initiation	GigCapital3 initiated with an Outperform at Northland » 07:33 04/13/21 04/13 07:33 04/13/21 07:33 GIK GigCapital3 $10.05 / -0.085 (-0.84%) Northland initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Events Options GIK GigCapital3 $10.05 / -0.085 (-0.84%) 03/01/21 Lightning eMotors teases use of electric delivery vans by Amazon 01/21/21 Lightning eMotors announces added production capacity 12/11/20 GigCapital3 rises 13.9% GIK GigCapital3 $10.05 / -0.085 (-0.84%) 03/12/21 Benchmark GigCapital3 initiated with a Buy at Benchmark GIK GigCapital3 $10.05 / -0.085 (-0.84%) 03/24/21 DHL Express deploying more electric vans in U.S., Green Car Congress says 11/19/20 Lightning EMotors in talks to go public via GigCapital3, Bloomberg reports 11/19/20 GigCapital3 in talks to bring Lightning eMotors public in merger, Bloomberg says GIK GigCapital3 $10.05 / -0.085 (-0.84%) 03/29/21 Charged: Tesla accepting bitcoin as form of payment for cars 04/21/21 GigCapital3, Inc. GIK GigCapital3 $10.05 / -0.085 (-0.84%) 03/01/21 GigCapital3 call volume above normal and directionally bullish 02/01/21 GigCapital3 call volume above normal and directionally bullish 01/14/21 GigCapital3 call volume above normal and directionally bullish 12/23/20 new option listings and one option delisting on December 23rd
Hot Stocks	Lincoln Electric names Lisa Shapiro as VP, corporate controller » 07:32 04/13/21 04/13 07:32 04/13/21 07:32 LECO Lincoln Electric $122.23 / +0.16 (+0.13%) Lincoln Electric Holdings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events LECO Lincoln Electric $122.23 / +0.16 (+0.13%) 10/27/20 Lincoln Electric sees Q4 organic sales to decline at similiar rate as Q3 10/27/20 Lincoln Electric expects cost reduction actions to generate $80M-$85M in 2020 10/27/20 Lincoln Electric raises quarterly dividend 4.1% to 51c per share 10/20/20 Lincoln Electric raises quarterly dividend to 51c from 49c per share LECO Lincoln Electric $122.23 / +0.16 (+0.13%) 02/16/21 Baird Lincoln Electric early cycle growth seen in 2021, says Baird 01/20/21 Vertical Research Lincoln Electric initiated with a Sell at Vertical Research 12/21/20 Barclays Lincoln Electric price target raised to $130 from $117 at Barclays 10/19/20 Barclays Lincoln Electric upgraded to Overweight on 'best-in-class' profile at Barclays LECO Lincoln Electric $122.23 / +0.16 (+0.13%) 02/12/21 Lincoln Electric reports Q4 adjusted EPS $1.24, consensus $1.06 10/27/20 Lincoln Electric reports Q3 adjusted EPS $1.10, consensus 78c 04/27/21 Lincoln Electric - LECO 04/22/21 Lincoln Electric Holdings Inc
Initiation	Connect Biopharma initiated with an Outperform at SVB Leerink » 07:32 04/13/21 04/13 07:32 04/13/21 07:32 CNTB Connect Biopharma $17.00 / +0.08 (+0.47%) SVB Leerink analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly CNTB Connect Biopharma $17.00 / +0.08 (+0.47%) 04/08/21 Connect Biopharma completes enrollment of CBP-201 Phase 2 trial CNTB Connect Biopharma $17.00 / +0.08 (+0.47%) 04:53 Today Piper Sandler Connect Biopharma initiated with an Overweight at Piper Sandler 19 Mar CNTB Connect Biopharma $17.00 / +0.08 (+0.47%) 03/20/21 Opening Day: China's Tuya raised $915M in U.S. IPO

Events

Earnings calls, analyst events, roadshows and more

EARS
Today at 08:00

Auris Medical - EARS Conference Calls
BFRA
Today at 08:00

Biofrontera - BFRA Conference Calls
OGI
Today at 08:00

Organigram - OGI Conference Calls
Today at 08:30

CPI Ex Food & Energy Y/Y: March 2021 Government Event
Today at 08:30

Consumer Price Index M/M: March 2021 Government Event
Today at 08:30

Consumer Price Index Y/Y: March 2021 Government Event
Today at 08:30

CPI Ex-Food & Energy M/M: March 2021 Government Event
MGA
Today at 08:30

Magna International, Inc. CL A Firm Sponsored Meetings
KKR
Today at 08:30

KKR & Co. Inc. Firm Sponsored Meetings
Today at 08:55

Redbook Store Sales Y/Y: 4/10/21 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays Priced at: $23.50 7.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank $35.10 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham $26.00-28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares
Fri	No deals

View All Syndicate Announcements »

Canaccord starts Verona Pharma with a Buy rating, $17 price target

TODAY'S FREE FLY STORIES

Get Full Fly Access